跳至主要内容
临床试验/NCT02407288
NCT02407288Unknown不适用

Transcranial Direct Current Stimulation as an add-on Treatment in SSRI-resistant Obsessive Compulsive Disorder : a Randomized Clinical Trial

Hôpital le Vinatier1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2015年3月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
46
试验地点
1
主要终点
score improvement on the Yale Brown Obsessive and Compulsive Scale after one month

研究概览

简要总结

The purpose of this study is to determine whether tDCS is effective as an add-on treatment in SSRI-resistant patients with obsessive and compulsive disorder

详细描述

Total number of scheduled patients to be recruited: 46 We used the effect size of the study of Ruffini and colleagues (2009) in which rTMS was used to target the left orbito frontal cortex to calculate the number of patients to be recruited. With a risk alpha of 5%, a power of 80%, the number of patients to be included was 46 with an anticipated rate of 10% of lost to follow-up patients. (calculation was made on the http://www.spc.univ-lyon1.fr/mfcalc/NSN/assistant.htm)

Statistical analysis to address the primary and secondary objectives:

Chi squared test will be applied for quantitative data.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients diagnosed with OCD according to DSM V criteria
  • •YBOCS score of 16 and above, stable (<20% of variation) during at least one month.
  • •have received for at least 12 weeks of which 6 weeks was either at the maximum tolerated dose or alternatively the manufacturer's recommended maxi- mum daily dose.
  • •age between 18 and 70
  • •voluntary and competent to consent

排除标准

  • •Major depressive disorder diagnosed with the DSM V criteria with a MADRS score >30 (actual)
  • •schizophrenia and other psychotic disorder
  • •drugs or alcohol abuse
  • •acutely suicidal
  • •significant head injury, or of any neurosurgical procedure with implanted material
  • •pregnant women

研究组 & 干预措施

active tDCS

Active Comparator

patients will received 2 sessions per day for 5 consecutive days. Each session will last 20 minutes. The tDCS device will deliver a direct current of 2mA during 20 minutes. Cathode will be localized in front of the left orbito-frontal on the FP3 point according to the EEG international reference. Anode will be localized in front of the right cerebellum 3 cm below the inion and 1 cm right from the midline

干预措施: transcranial dirrect current stimulation (Device)

SHAM tDCS

Placebo Comparator

The same procedure will be applied except that the tDCS device will only deliver a current stimulation for the 10 first seconds.

干预措施: Sham tDCS (Device)

结局指标

主要结局

score improvement on the Yale Brown Obsessive and Compulsive Scale after one month

时间窗: 1 month after treatment

% of improvement compare to baseline

次要结局

  • score improvement on the Yale Brown Obsessive and Compulsive Scale after 3 months(3 months after treatment)
  • Number of responders on the YBOCS(1 month after treatment)

研究者

发起方
Hôpital le Vinatier
申办方类型
Other
责任方
Principal Investigator
主要研究者

BATION Rémy

Dr Rémy Bation

Hôpital le Vinatier

研究点 (1)

Loading locations...

相似试验